Titan Biotech Ltd — Dividend/Bonus, 03-09-2026: Corp. Action

Titan Biotech's Board has approved a 1:4 bonus share issue, meaning one new equity share for every four held, pending shareholder approval. This will increase the paid-up capital from Rs. 8.26 Crore to Rs. 10.33 Crore, funded by available reserves of Rs. 162.58 Crore. The company also approved an increase in authorized share capital from Rs. 10 Crore to Rs. 10.40 Crore. Shareholders will vote on these and the re-appointment of Independent Director Mr. Rohit Jain at the Annual General Meeting on September 29. A final dividend of Rs. 0.50 per share was also noted, with September 22 as the record date.